OTC - ACTIVE INGREDIENT SECTION
Active Ingredients
Silicea (Silicon dioxide) 6X
Active Ingredients
Silicea (Silicon dioxide) 6X
Uses
For the temporary relief from mild acne and brittle nails
Warnings
Do not use if you ever had an allergic reaction to this product or any of its ingredients.
Stop use and ask a doctor if symptoms persist or worsen.
If you are pregnant or breastfeeding, ask a healthcare practitioner before use.
Keep out of reach of children.
In case of overdose, get medical help or contact a Poison Control Center right away.
If you are pregnant or breastfeeding, ask a healthcare practitioner before use.
Keep out of reach of children.
In case of overdose, get medical help or contact a Poison Control Center right away.
Stop use and ask a doctor if symptoms persist or worsen.
Inactive Ingredients
Lactose monohydrate (milk), magnesium stearate, sodium carboxymethylcellulose, xylitol
Directions
Tip bottle silghtly allowing for tablets to fall into the cap.
Use cap to drop tablets into mouth and allow them to dissolve under the tongue.
Adults and children (12 years and older): Take 1 to 4 tablets, one to four times daily, or as recommended by your
healthcare practitioner.
Children (under 12 years): Take under the direction of your healthcare practitioner.
Uses
for the temporary relief from mild acne and brittle nails.
Directions
Tip bottle slightly allowing for tablets to fall into cap.
Use cap to drop tablets into mouth and allow them to dissolve under the tongue.
Adults and Adolescents (12 years and older): Take 1 to 4 tablets, one to four times daily, or as recommended by your healthcare practitioner.
Children (under 12 years): Take under the direction of your healthcare practitioner.
Other information
Do not use if seal is missing or
broken.
Store in a cool, dry place.
Contents may not fill package in order
to accommodate required labeling.
Please rely on stated quantity.
NDC 62106-1061-2
UNDA
tissue salt
SILICEA 6X
Homeopathic Remedy
Cell Salt
For the temporary relief from mild acne and brittle nails.
100 Tablets
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 62106-1061-2 | SILICEA 6X | 1 in 1 CARTON | TABLET | 1 | 7 | |
| 62106-1061-2 | SILICEA 6X | 100 in 1 BOTTLE, GLASS | TABLET | 100 | 7 |
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 62106-1061 | SILICEA 6X (SILICEA) TABLET [SEROYAL USA] | 7 | Current NDC, Legacy NDC, 2 package rows | 20210715_156cb778-c6a8-0681-e054-00144ff8d46c.zip |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| SILICON DIOXIDE | ACTIVE INGREDIENT | ETJ7Z6XBU4 | 1 | |
| SILICON DIOXIDE | ACTIVE MOIETY | ETJ7Z6XBU4 | 1 | |
| CROSCARMELLOSE SODIUM | INACTIVE INGREDIENT | M28OL1HH48 | 1 | |
| LACTOSE MONOHYDRATE | INACTIVE INGREDIENT | EWQ57Q8I5X | 1 | |
| MAGNESIUM STEARATE | INACTIVE INGREDIENT | 70097M6I30 | 1 | |
| XYLITOL | INACTIVE INGREDIENT | VCQ006KQ1E | 1 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 62106-1061 | 62106-1061-2 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| SILICON DIOXIDE | ETJ7Z6XBU4 | ACTIB |
| LACTOSE MONOHYDRATE | EWQ57Q8I5X | IACT |
| XYLITOL | VCQ006KQ1E | IACT |
| CROSCARMELLOSE SODIUM | M28OL1HH48 | IACT |
| MAGNESIUM STEARATE | 70097M6I30 | IACT |
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | TABLET / SUBLINGUAL | 17.5 mg | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | TABLET / SUBLINGUAL | 17.5 mg | ||
| XYLITOL | XYLITOL | VCQ006KQ1E | TABLET / ORAL | 15.04 mg | ||
| CROSCARMELLOSE SODIUM | CROSCARMELLOSE SODIUM | M28OL1HH48 | TABLET / SUBLINGUAL | 10 mg | ||
| LACTOSE MONOHYDRATE | LACTOSE MONOHYDRATE | EWQ57Q8I5X | TABLET / SUBLINGUAL | 505 mg | ||
| XYLITOL | XYLITOL | VCQ006KQ1E | TABLET / ORAL | 15.04 mg | ||
| XYLITOL | XYLITOL | VCQ006KQ1E | SPRAY / SUBLINGUAL | 22 mg | ||
| CROSCARMELLOSE SODIUM | CROSCARMELLOSE SODIUM | M28OL1HH48 | TABLET / SUBLINGUAL | 10 mg | ||
| XYLITOL | XYLITOL | VCQ006KQ1E | SPRAY / SUBLINGUAL | 22 mg | ||
| LACTOSE MONOHYDRATE | LACTOSE MONOHYDRATE | EWQ57Q8I5X | TABLET / SUBLINGUAL | 505 mg |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| SILICEA 6X | SILICEA | Seroyal USA | 156cb778-c6a8-0681-e054-00144ff8d46c | 2021-07-14 | Warnings | 62106-1061-2 62106-1061 62106106102 c71e003c-988d-ad32-e053-2995a90a9a28 156cb778-c6a8-0681-e054-00144ff8d46c |
Adverse event summaries are temporarily unavailable. Other product information remains available.